NSE · AI Signal & Stock Analysis · Bearish
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for SHILPAMED is Bearish ↓ (moderate move); technical trend down-trend; trading at ₹604.05 (-1.52% today); neutral (RSI 52).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | Down-trend (since 2026-07-24) |
| Price | ₹604.05 |
| Change today | -1.52% |
| RSI (14) | 52.20 |
| Relative volume | 0.23 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹16,077 Cr |
| P/E | 54.19 |
| Cap category | Mid Cap |
| 52-week high | -6.5% away |
| 52-week low | +126.2% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for SHILPAMED (Shilpa Medicare Limited) is Bearish with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
SHILPAMED's RSI is neutral (RSI 52). A reading above 70 is typically overbought and below 30 oversold.
SHILPAMED is trading about 6% below its 52-week high and 126% above its 52-week low as of Aug 14 2026, 6:50 PM.
SHILPAMED's market capitalisation is ₹16,077 Cr as of Aug 14 2026, 6:50 PM.
SHILPAMED is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.